<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>44(5)</volume><submitter>Nishimoto K</submitter><pubmed_abstract>Primary aldosteronism (PA) is mainly clinically classified as unilateral aldosterone-producing adenoma (APA) or bilateral idiopathic hyperaldosteronism. Immunohistochemistry for aldosterone synthase reveals a diverse PA pathology, including pathological APA and aldosterone-producing cell clusters. The relationship between PA pathology and adrenalectomy outcomes was examined herein. Data from 219 unilaterally adrenalectomized PA cases were analyzed. Pathological analyses revealed diverse putative aldosterone-producing lesions. Postoperative biochemical outcomes in 114 cases (test cohort) were classified as complete success (n = 85), partial success (n = 19), and absent success (n = 10). Outcomes in the large and small PA lesion groups, rather than between PA lesion types, were compared at f</pubmed_abstract><journal>Hypertension research : official journal of the Japanese Society of Hypertension</journal><pagination>498-507</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8099725</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Diverse pathological lesions of primary aldosteronism and their clinical significance.</pubmed_title><pmcid>PMC8099725</pmcid><pubmed_authors>Suzuki T</pubmed_authors><pubmed_authors>Ichijo T</pubmed_authors><pubmed_authors>Nishimoto K</pubmed_authors><pubmed_authors>Araki R</pubmed_authors><pubmed_authors>Shibata H</pubmed_authors><pubmed_authors>Katabami T</pubmed_authors><pubmed_authors>Izawa S</pubmed_authors><pubmed_authors>Kobayashi H</pubmed_authors><pubmed_authors>Kawamura T</pubmed_authors><pubmed_authors>Tsuiki M</pubmed_authors><pubmed_authors>Matsuda Y</pubmed_authors><pubmed_authors>Fukuoka T</pubmed_authors><pubmed_authors>Yoshiro C</pubmed_authors><pubmed_authors>Sone M</pubmed_authors><pubmed_authors>Kurihara I</pubmed_authors><pubmed_authors>Ogo A</pubmed_authors><pubmed_authors>Naruse M</pubmed_authors><pubmed_authors>Tanaka Y</pubmed_authors><pubmed_authors>Hashimoto S</pubmed_authors><pubmed_authors>Yasuda M</pubmed_authors><pubmed_authors>Fujii Y</pubmed_authors><pubmed_authors>Rakugi H</pubmed_authors><pubmed_authors>Miyauchi S</pubmed_authors><pubmed_authors>Watanabe M</pubmed_authors><pubmed_authors>Yoshimoto T</pubmed_authors><pubmed_authors>Otsuki M</pubmed_authors><pubmed_authors>Takahashi K</pubmed_authors><pubmed_authors>Kamemura K</pubmed_authors><pubmed_authors>Yamamoto K</pubmed_authors><pubmed_authors>Fujita M</pubmed_authors><pubmed_authors>JRAS Study Group</pubmed_authors><pubmed_authors>Itoh H</pubmed_authors><pubmed_authors>Seki T</pubmed_authors><pubmed_authors>Kawashima J</pubmed_authors><pubmed_authors>Yanase T</pubmed_authors><pubmed_authors>Shibayama Y</pubmed_authors><pubmed_authors>Kai T</pubmed_authors><pubmed_authors>Yamada M</pubmed_authors><pubmed_authors>Umakoshi H</pubmed_authors><pubmed_authors>Wada N</pubmed_authors><pubmed_authors>Takeda Y</pubmed_authors><pubmed_authors>Inagaki N</pubmed_authors><pubmed_authors>Ogawa Y</pubmed_authors><pubmed_authors>Okamura S</pubmed_authors><pubmed_authors>Yoshikawa Y</pubmed_authors><pubmed_authors>Sakamoto R</pubmed_authors><pubmed_authors>Fukuda H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Diverse pathological lesions of primary aldosteronism and their clinical significance.</name><description>Primary aldosteronism (PA) is mainly clinically classified as unilateral aldosterone-producing adenoma (APA) or bilateral idiopathic hyperaldosteronism. Immunohistochemistry for aldosterone synthase reveals a diverse PA pathology, including pathological APA and aldosterone-producing cell clusters. The relationship between PA pathology and adrenalectomy outcomes was examined herein. Data from 219 unilaterally adrenalectomized PA cases were analyzed. Pathological analyses revealed diverse putative aldosterone-producing lesions. Postoperative biochemical outcomes in 114 cases (test cohort) were classified as complete success (n = 85), partial success (n = 19), and absent success (n = 10). Outcomes in the large and small PA lesion groups, rather than between PA lesion types, were compared at f</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 May</publication><modification>2025-04-22T02:08:49.992Z</modification><creation>2025-04-05T20:12:59.743Z</creation></dates><accession>S-EPMC8099725</accession><cross_references><pubmed>33437027</pubmed><doi>10.1038/s41440-020-00579-w</doi></cross_references></HashMap>